Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Digestive Diseases

The Latest in Diagnosis and Treatment of Gastrointestinal Disorders

Vol. 36, No. 1, 2018

Issue release date: October 2017

Add all to MyReading List

Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors

Joo M. · Park J. · Chun H.
Dig Dis 2018;36:1–14 (DOI:10.1159/000480149)

Task-Shifting in Surveillance after Surgery for Colorectal Cancer: Addressing the Right Question?

Søreide K.
Dig Dis 2018;36:15–16 (DOI:10.1159/000481431)
Free Access
Original Paper

Nonphysician Clinicians in the Follow-Up of Resected Patients with Colorectal Cancer

Coebergh van den Braak R.R.J. · Lalmahomed Z.S. · Büttner S. · Hansen B.E. · Ijzermans J.N.M. · on behalf of the MATCH Study Group
Dig Dis 2018;36:17–25 (DOI:10.1159/000478848)

Replication Protein A 3 Is Associated with Hepatocellular Carcinoma Tumorigenesis and Poor Patient Survival

Xiao W. · Zheng J. · Zhou B. · Pan L.
Dig Dis 2018;36:26–32 (DOI:10.1159/000478977)

Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids

Asl Baakhtari S. · McCombie A. · ten Bokkel Huinink S. · Irving P. · Siegel C.A. · Mulder R. · Mulder C.J. · Gearry R.
Dig Dis 2018;36:33–39 (DOI:10.1159/000478772)

Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors

Ohem J. · Hradsky O. · Zarubova K. · Copova I. · Bukovska P. · Prusa R. · Malickova K. · Bronsky J.
Dig Dis 2018;36:40–48 (DOI:10.1159/000477962)

Risk Stratification of Patients with Crohn's Disease: A Retrospective Analysis of Clinical Decision Making and Its Impact on Long-Term Outcome

Mosli M. · Sabbahi H. · Alyousef H. · Abdulhaq M. · Hadadi A. · Aljahdali E. · Jawa H. · Bazarah S. · Qari Y.
Dig Dis 2018;36:49–55 (DOI:10.1159/000477613)

Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders

Lopetuso L.R. · Petito V. · Graziani C. · Schiavoni E. · Paroni Sterbini F. · Poscia A. · Gaetani E. · Franceschi F. · Cammarota G. · Sanguinetti M. · Masucci L. · Scaldaferri F. · Gasbarrini A.
Dig Dis 2018;36:56–65 (DOI:10.1159/000477205)

High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury

Shan J. · Lei H. · Shi W. · Sun X. · Tang Y. · Ren C.
Dig Dis 2018;36:66–71 (DOI:10.1159/000477203)

Routine Pouchoscopy Prior to Ileostomy Takedown May Not Be Necessary in Patients with Chronic Ulcerative Colitis

Cai J.X. · Barrow J. · Parian A. · Brant S.R. · Dudley-Brown S. · Efron J. · Fang S. · Gearhart S. · Marohn M. · Safar B. · Truta B. · Wick E. · Lazarev M.
Dig Dis 2018;36:72–77 (DOI:10.1159/000475808)

Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

Labenz C. · Prenosil V. · Koch S. · Huber Y. · Marquardt J.U. · Schattenberg J.M. · Galle P.R. · Weinmann A. · Wörns M.-A.
Dig Dis 2018;36:78–88 (DOI:10.1159/000477578)